# TriSalus Life Sciences, Inc. (TLSI): MoatMap facts

As of 24 Oct 2026. Research data, not investment advice.

As of 24 Oct 2026, MoatMap's StockRank for TriSalus Life Sciences, Inc. (TLSI) is 16/100, ranked against 24,000+ stocks in 35 markets (Quality 34, Value 23, Momentum 39, each scored against its sector).

- StockRank: 16/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 34, Value 23, Momentum 39: each a 0-100 percentile within Healthcare.
- Position: #22,474 overall, #2,035 in Healthcare.
- Listing: United States, NGM; Healthcare / Medical Devices.
- Last close: 3.62 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors bought USD 1.8M; directors sold USD 6K.

Source: https://moatmap.ai/stock/TLSI
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker